To verify whether the targeted binding of tRF-19-R118LOJX with S100A11 could affect the glioma cell proliferation, migration and in vitro VM formation, the expression of S100A11 was knocked down in the tRF-19-R118LOJX inhibitor group (Fig. 8E). This evidence concerns the gene S100A11 and central nervous system cancer.